Influence of gadolinium, field-strength and sequence type on quantified perfusion values in phase-resolved functional lung MRI

Purpose The purpose of this study is to evaluate the influences of gadolinium-based contrast agents, field-strength and different sequences on perfusion quantification in Phase-Resolved Functional Lung (PREFUL) MRI. Materials and methods Four cohorts of different subjects were imaged to analyze influences on the quantified perfusion maps: 1) at baseline and after 2 weeks to obtain the reproducibility (26 COPD patients), 2) before and after the administration of gadobutrol (11 COPD, 2 PAH and 1 asthma), 3) at 1.5T and 3T (12 healthy, 4 CF), and 4) with different acquisition sequences spoiled gradient echo (SPGR) and balanced steady-state free precession (bSSFP) (11 COPD, 7 healthy). Wilcoxon-signed rank test, Bland-Altman plots, voxelwise Pearson correlations, normalized histogram analyses with skewness and kurtosis and two-sample Kolmogorov-Smirnov tests were performed. P value ≤ 0.05 was considered statistically significant. Results In all cohorts, linear correlations of the perfusion values were significant with correlation coefficients of at least 0.7 considering the entire lung (P<0.01). The reproducibility cohort revealed stable results with a similar distribution. In the gadolinium cohort, the quantified perfusion increased significantly (P<0.01), and no significant change was detected in the histogram analysis. In the field-strength cohort, no significant change of the quantified perfusion was shown, but a significant increase of skewness and kurtosis at 3T (P = 0.01). In the sequence cohort, the quantified perfusion decreased significantly in the bSSFP sequence (P<0.01) together with a significant decrease of skewness and kurtosis (P = 0.02). The field-strength and sequence cohorts had differing probability distribution in the two-sample Kolmogorov-Smirnov tests. Conclusion We observed a high susceptibility of perfusion quantification to gadolinium, field-strength or MRI sequence leading to distortion and deviation of the perfusion values. Future multicenter studies should strictly adhere to the identical study protocols to generate comparable results.

[1]  J. Hohlfeld,et al.  PREFUL MRI Depicts Dual Bronchodilator Changes in COPD: A Retrospective Analysis of a Randomized Controlled Trial , 2022, Radiology. Cardiothoracic imaging.

[2]  E. Tam,et al.  Clinical Feasibility of Structural and Functional MRI in Free‐Breathing Neonates and Infants , 2022, Journal of magnetic resonance imaging : JMRI.

[3]  P. Evans,et al.  Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration , 2022, Archives of Toxicology.

[4]  F. Wacker,et al.  Perfusion quantification using voxel‐wise proton density and median signal decay in PREFUL MRI , 2021, Magnetic resonance in medicine.

[5]  F. Wacker,et al.  Comparison of phase-resolved functional lung (PREFUL) MRI derived perfusion and ventilation parameters at 1.5T and 3T in healthy volunteers. , 2020, PloS one.

[6]  F. Wacker,et al.  Flow Volume Loop and Regional Ventilation Assessment Using Phase‐Resolved Functional Lung (PREFUL) MRI: Comparison With 129Xenon Ventilation MRI and Lung Function Testing , 2020, Journal of magnetic resonance imaging : JMRI.

[7]  F. Wacker,et al.  3D phase‐resolved functional lung ventilation MR imaging in healthy volunteers and patients with chronic pulmonary disease , 2020, Magnetic resonance in medicine.

[8]  S. Favaro,et al.  Quantitative , 2020, Psychology through Critical Auto-Ethnography.

[9]  T. Derlin,et al.  Validation of Automated Perfusion‐Weighted Phase‐Resolved Functional Lung (PREFUL)‐MRI in Patients With Pulmonary Diseases , 2019, Journal of magnetic resonance imaging : JMRI.

[10]  O. Bieri,et al.  Functional lung imaging with transient spoiled gradient echo , 2018, Magnetic resonance in medicine.

[11]  H. Kauczor,et al.  Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosis. , 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[12]  J. Bloem,et al.  MR signal intensity: staying on the bright side in MR image interpretation , 2018, RMD Open.

[13]  F. Wacker,et al.  Feasibility of quantitative regional ventilation and perfusion mapping with phase‐resolved functional lung (PREFUL) MRI in healthy volunteers and COPD, CTEPH, and CF patients , 2018, Magnetic resonance in medicine.

[14]  F. Wacker,et al.  Low‐pass imaging of dynamic acquisitions (LIDA) with a group‐oriented registration (GOREG) for proton MR imaging of lung ventilation , 2017, Magnetic resonance in medicine.

[15]  D. Bluemke,et al.  Three‐dimensional T1 and T2* mapping of human lung parenchyma using interleaved saturation recovery with dual echo ultrashort echo time imaging (ITSR‐DUTE) , 2017, Journal of magnetic resonance imaging : JMRI.

[16]  Oliver Bieri,et al.  Ultra‐fast Steady‐State Free Precession Pulse Sequence for Fourier Decomposition Pulmonary MRI , 2016, Magnetic resonance in medicine.

[17]  Andrew Zisserman,et al.  Very Deep Convolutional Networks for Large-Scale Image Recognition , 2014, ICLR.

[18]  Thomas Henzler,et al.  Quantitative lung perfusion evaluation using fourier decomposition perfusion MRI , 2014, Magnetic resonance in medicine.

[19]  X. Zhang,et al.  In vivo blood T1 measurements at 1.5 T, 3 T, and 7 T , 2013, Magnetic resonance in medicine.

[20]  Arno Klein,et al.  A reproducible evaluation of ANTs similarity metric performance in brain image registration , 2011, NeuroImage.

[21]  Jian Sun,et al.  Guided Image Filtering , 2010, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[22]  E. Merkle,et al.  A review of MR physics: 3T versus 1.5T. , 2007, Magnetic resonance imaging clinics of North America.

[23]  K. Scheffler,et al.  Principles and applications of balanced SSFP techniques , 2003, European Radiology.

[24]  R E Lenkinski,et al.  Pulmonary perfusion: respiratory-triggered three-dimensional MR imaging with arterial spin tagging--preliminary results in healthy volunteers. , 1999, Radiology.

[25]  J Listerud,et al.  T2* and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging. , 1999, European journal of radiology.

[26]  E. Moser,et al.  Proton NMR relaxation times of human blood samples at 1.5 T and implications for functional MRI. , 1997, Cellular and molecular biology.

[27]  Robert R. Edelman,et al.  Noninvasive assessment of regional ventilation in the human lung using oxygen–enhanced magnetic resonance imaging , 1996, Nature Medicine.

[28]  M. Moseley,et al.  Contrast-enhanced MR imaging of the lung: assessments of ventilation and perfusion. , 1992, Radiology.

[29]  V. Gulani,et al.  Quantitative MRI: Rationale and Challenges , 2020 .